HK1212434A1 - Tnt based diagnosis of paroxysmal atrial fibrillation tnt - Google Patents

Tnt based diagnosis of paroxysmal atrial fibrillation tnt

Info

Publication number
HK1212434A1
HK1212434A1 HK16100057.2A HK16100057A HK1212434A1 HK 1212434 A1 HK1212434 A1 HK 1212434A1 HK 16100057 A HK16100057 A HK 16100057A HK 1212434 A1 HK1212434 A1 HK 1212434A1
Authority
HK
Hong Kong
Prior art keywords
tnt
atrial fibrillation
based diagnosis
paroxysmal atrial
paroxysmal
Prior art date
Application number
HK16100057.2A
Other languages
English (en)
Chinese (zh)
Inventor
Dirk Block
Roberto Latini
Serge Masson
Ursula-Henrike Wienhues-Thelen
Christian Zaugg
Andre Ziegler
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47143752&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1212434(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of HK1212434A1 publication Critical patent/HK1212434A1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869—Interleukin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4712—Muscle proteins, e.g. myosin, actin, protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4737—C-reactive protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4745—Insulin-like growth factor binding protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G01N2333/5412—IL-6
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Brain natriuretic peptide [BNP, proBNP]; Cardionatrin; Cardiodilatin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/326—Arrhythmias, e.g. ventricular fibrillation, tachycardia, atrioventricular block, torsade de pointes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HK16100057.2A 2012-11-09 2016-01-06 Tnt based diagnosis of paroxysmal atrial fibrillation tnt HK1212434A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12191996 2012-11-09
PCT/EP2013/073476 WO2014072500A1 (en) 2012-11-09 2013-11-11 Tnt based diagnosis of paroxysmal atrial fibrillation

Publications (1)

Publication Number Publication Date
HK1212434A1 true HK1212434A1 (en) 2016-06-10

Family

ID=47143752

Family Applications (2)

Application Number Title Priority Date Filing Date
HK16100057.2A HK1212434A1 (en) 2012-11-09 2016-01-06 Tnt based diagnosis of paroxysmal atrial fibrillation tnt
HK18115419.1A HK1256334A1 (zh) 2012-11-09 2018-12-03 陣發性心房纖顫的基於tnt的診斷

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK18115419.1A HK1256334A1 (zh) 2012-11-09 2018-12-03 陣發性心房纖顫的基於tnt的診斷

Country Status (8)

Country Link
US (3) US20150233946A1 (de)
EP (1) EP2917736B1 (de)
JP (2) JP6366594B2 (de)
CN (2) CN108120837B (de)
CA (1) CA2886698C (de)
ES (1) ES2774288T3 (de)
HK (2) HK1212434A1 (de)
WO (1) WO2014072500A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2681955T3 (es) 2013-01-17 2018-09-17 Astute Medical, Inc. Métodos y composiciones para el diagnóstico y pronóstico de lesión renal e insuficiencia renal
GB201413081D0 (en) * 2014-07-23 2014-09-03 Univ Birmingham Markers for AF
US10231639B2 (en) 2016-04-19 2019-03-19 Roche Diagnostics Operations, Inc. Algorithm of NTproBNP and hand held ECG to detect arrhythmia in an elderly population
EP3472622B1 (de) * 2016-06-17 2020-08-05 Roche Diagnostics GmbH Zirkulierendes angiopoietin-2 (ang-2) zur vorhersage des erneuten auftretens von vorhofflimmern
EP3279665B1 (de) * 2016-08-04 2020-07-08 Roche Diagniostics GmbH Zirkulierende esm-1 (endocan) bei der beurteilung von vorhofflimmern
KR102356418B1 (ko) 2017-06-13 2022-02-08 에프. 호프만-라 로슈 아게 심방 세동 (af) 의 평가를 위한 지방산 결합 단백질 3
CN111480081A (zh) * 2017-12-13 2020-07-31 豪夫迈·罗氏有限公司 用于预测脑卒中的循环血管生成素-2(Ang-2)和胰岛素样生长因子结合蛋白7(IGFBP7)
KR20210044216A (ko) * 2018-08-10 2021-04-22 에프. 호프만-라 로슈 아게 심방세동-관련 뇌졸중 평가를 위한 ces-2 (카르복실에스테라제-2)
JP2021535370A (ja) * 2018-08-16 2021-12-16 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 心房細動および抗凝固療法の評価における循環ｔｆｐｉ−２（組織因子経路阻害剤２）
EP3841381A1 (de) * 2018-08-22 2021-06-30 Roche Diagnostics GmbH Zirkulierende spon-1 (spondin-1) bei der beurteilung von vorhofflimmern
WO2020039085A1 (en) * 2018-08-24 2020-02-27 Roche Diagnostics Gmbh Circulating fgfbp-1 (fibroblast growth factor-binding protein 1) in the assessment of atrial fibrillation and for the prediction of stroke
CN109871808B (zh) * 2019-02-21 2021-03-02 天津惊帆科技有限公司 房颤模型训练、检测方法和装置
EP3730942A1 (de) * 2019-04-26 2020-10-28 Fundació Hospital Universitari Vall d' Hebron - Institut de Recerca Diagnosemarker für vorhofflimmern
WO2021118796A1 (en) * 2019-12-13 2021-06-17 Ischemia Care Llc Biomarkers for the diagnosis of atrial fibrillation cause of stroke
JP2023537749A (ja) 2020-08-14 2023-09-05 エフ． ホフマン－ラ ロシュ アーゲー 無症候性脳梗塞及び認知低下の評価のためのｉｇｆｂｐ７
EP4222499A1 (de) 2020-09-30 2023-08-09 F. Hoffmann-La Roche AG Zirkulierendes total-nt-probnp (glycosyliertes und unglycosyliertes nt-probnp) und sein verhältnis mit nt-probnp (unglycosyliertem nt-probnp) bei der beurteilung von vorhofflimmern
EP4169946A1 (de) 2021-10-25 2023-04-26 Bionote, Inc. Spezifisch an nt-probnp bindende antikörper und verwendung davon

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
GB9211686D0 (en) 1992-06-03 1992-07-15 Medisinsk Innovation A S Chemical compounds
US7632647B2 (en) 2001-04-13 2009-12-15 Biosite Incorporated Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes
EP1666881B1 (de) 2001-05-04 2010-02-17 Biosite Incorporated Diagnostische Marker der akuten koronaren Syndrome und ihre Verwendungen
JP2006526140A (ja) 2002-12-24 2006-11-16 バイオサイト インコーポレイテッド 鑑別診断のためのマーカーおよびその使用方法
CA3086149A1 (en) 2006-04-04 2007-10-11 Singulex, Inc. Highly sensitive system and methods for analysis of troponin
WO2010007041A1 (en) * 2008-07-14 2010-01-21 Roche Diagnostics Gmbh Multimarker panel for diagnosing, monitoring and selecting the therapy for patients with heart failure
CA2732201A1 (en) 2008-08-13 2010-02-18 F. Hoffmann-La Roche Ag D-dimer, troponin, nt-probnp for pulmonary embolism
NZ595918A (en) * 2009-04-03 2013-07-26 Decode Genetics Ehf Genetic markers for risk management of atrial fibrillation and stroke
ES2627337T3 (es) 2010-08-26 2017-07-27 F. Hoffmann-La Roche Ag Uso de biomarcadores para controlar una medicación en un sujeto que padece insuficiencia cardíaca
BR122021026652B1 (pt) 2011-10-17 2022-08-23 F. Hoffmann-La Roche Ag Método in vitro para diagnosticar fibrilação atrial intermitente, uso de uma troponina cardíaca e dispositivo para diagnosticar fibrilação atrial intermitente

Also Published As

Publication number Publication date
ES2774288T3 (es) 2020-07-20
CN108120837B (zh) 2021-06-22
WO2014072500A1 (en) 2014-05-15
CA2886698C (en) 2019-02-19
US20230062697A1 (en) 2023-03-02
JP2016502659A (ja) 2016-01-28
JP2018151411A (ja) 2018-09-27
CN104769436A (zh) 2015-07-08
US20150233946A1 (en) 2015-08-20
JP6366594B2 (ja) 2018-08-01
CN108120837A (zh) 2018-06-05
US20170074892A1 (en) 2017-03-16
EP2917736A1 (de) 2015-09-16
JP6654668B2 (ja) 2020-02-26
CA2886698A1 (en) 2014-05-15
HK1256334A1 (zh) 2019-09-20
EP2917736B1 (de) 2019-12-25
CN104769436B (zh) 2018-01-26

Similar Documents

Publication Publication Date Title
HK1256334A1 (zh) 陣發性心房纖顫的基於tnt的診斷
HK1212388A1 (en) Methods of tissue generation
HK1212261A1 (en) Methods of tissue generation
EP3636148C0 (de) Wearable-herzmonitor
HK1211844A1 (en) Treatment of pulmonary disease
EP2897522A4 (de) Physiologisches mapping für arrhythmie
EP2846701A4 (de) Indikator für rechten vorhof
IL227017A0 (en) Evaluation of ablation in real time from EKG signals.
EP2814995A4 (de) Titanlegierungen
IL229457B (en) Multi-channel ecg measurement
GB201321559D0 (en) Diagnosis of the condition of apparatus
EP2817061A4 (de) Verbesserte ablationstechniken zur behandlung von vorhofflimmern
IL225773A0 (en) Discovery of the activation time of the heart
EP2656779A4 (de) Endoskop
EP2836114A4 (de) Messung physiologischer gehirnparameter mittels bioimpedanz
EP2696751A4 (de) Elektrokardiographische beurteilung eines arrhythmierisikos
HK1211480A1 (en) External preparation for skin
GB2508667B (en) Diagnosis of the condition of apparatus
GB2500893B (en) Spirometer
PL2851005T3 (pl) Głowica detekcyjna stetoskopu
EP2712550A4 (de) Lanzette
PL2934437T3 (pl) Zastosowanie soli glinu w zwalczaniu potliwości pod wpływem stresu
HUE042708T2 (hu) Szívelégtelenség diagnosztika
GB201221046D0 (en) Method of diagnosis
TWM432281U (en) Hat structure of beekeeping jumpsuit